
zzso zzso and the zzso of some chronic diseases are dependent on host innate and zzso immune zzso Both responses are associated with abnormal zzso production within zzso zzso Over the past two decades, the availability of zzso zzso and zzso zzso zzso has prompted a therapeutic approach that aims to supply zzso zzso against deleterious zzso through either passive zzso zzso of large quantities of high affinity zzso prepared ex zzso or active zzso zzso of specific zzso using zzso zzso zzso Both passive and active zzso can zzso zzso and effectively be used, as has been documented by animal zzso and confirmed by clinical zzso Novel zzso therapeutic compounds, based on passive zzso zzso are now available to treat zzso arthritis zzso and have been shown to help control zzso in cancer zzso Clinical trials using zzso to treat allergic disorders are also zzso However, the induction of zzso zzso may restrict the long-term use of zzso zzso using zzso or zzso zzso We propose that greater consideration should be given to active zzso zzso 

